# Impact of SAVR and TAVR on Patient's Activity and Mobility

> **NCT03843320** · — · SUSPENDED · sponsor: **University of Padova** · enrollment: 340 (estimated)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **DEVICE:** SAPIEN 3
- **DEVICE:** SAPIEN XT
- **DEVICE:** INSPIRIS RESILIA
- **DEVICE:** EDWARDS INTUITY
- **DEVICE:** Carpentier-Edwards PERIMOUNT Magna-Ease

## Key facts

- **NCT ID:** NCT03843320
- **Lead sponsor:** University of Padova
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2021-12
- **Primary completion:** 2023-12
- **Final completion:** 2024-12
- **Target enrollment:** 340 (ESTIMATED)
- **Why stopped:** Reassessing study feasibility
- **Last updated:** 2020-12-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03843320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03843320, "Impact of SAVR and TAVR on Patient's Activity and Mobility". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03843320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*